Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case‐control study-Reference-Cited by-同舟云学术

Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case‐control study

Published:2020-12-02 Issue:2 Volume:41 Page:271-275
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Fiore Vito¹,Ranieri Roberto²,Dell’Isola Serena³,Pontali Emanuele⁴^ORCID,Barbarini Giorgio⁵,Prestileo Tullio⁶^ORCID,Marri Daniele⁷,Starnini Giulio³,Sotgiu Giovanni¹^ORCID,Madeddu Giordano¹^ORCID,Babudieri Sergio¹^ORCID,

Affiliation:

1. Department of Medical Surgical and Experimental Sciences University of Sassari Sassari Italy

2. Penitentiary Infectious Diseases Unit A.O. Santi Paolo e CarloUniversity of Milan Milan Italy

3. Medicina Protetta‐Unit of Infectious Diseases Belcolle Hospital Viterbo Italy

4. Infectious Disease Unit Galliera Hospital Genoa Italy

5. 2nd Division of Infectious Diseases Policlinico San Matteo Hospital Pavia Italy

6. ARNASOspedale Civico‐Benefratelli Palermo Italy

7. Infectious Diseases Unit, A.O. Santa Maria alle Scotte Siena Italy

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14745

Reference20 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings;Weinbaum C;MMWR Recomm Rep,2003

3. Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis

4. Blood born viral infections, sexually transmitted diseases and latent tuberculosis in italian prisons: a preliminary report of a large multicenter study;Sagnelli E;Eur Rev Med Pharmacol Sci,2012

5. Polaris observatory data.http://polarisobservatory.org/polaris/graphs.htm. Accessed April 2 2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Data on the Use of Glecaprevir/Pibrentasvir in the Treatment of Hepatitis C: Is Shorter Treatment Possible?;Viral Hepatitis Journal;2024-08-28

2. Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population;JHEP Reports;2024-01

3. Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations;Healthcare;2023-07-24

4. Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study;Liver International;2023-04-30

5. Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network;Viruses;2023-02-10